EP2648750
ANTIBODY FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.12.2011EP published:
25.1.2017EP application number:
11808178.5
EPO information:
European Patent Register
Max expiry date:
7.12.2031
Title:
ANTIBODY FORMULATION
Timeline
Today
8.12.2011EP application
25.1.2017EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
COSENZA, MartaAddress:
Basel, CH
Name:
HEUSSER, ChristophAddress:
Basel, CH
Name:
NEUGEBAUER, JuliaAddress:
Planegg, DE
Name:
SCHAADT, EvelineAddress:
Planegg, DE
Name:
URLINGER, StefanieAddress:
Planegg, DE
Name:
WOISETSCHLAEGER, MaximilianAddress:
Oberwil, CH
Priority
Number:
421650 PDate:
10.12.2010Country:
US
Classification
Categories:
C07K 16/28, A61K 9/19, A61K 39/395, A61K 9/08, A61K 47/26, A61K 47/18